Tribune: Abbott didn't want all of Wyeth

Abbott Laboratories, rumored to be interested in the takeover of drug giant Wyeth, may only have been interested in pieces of the New Jersey-based maker of vaccines and drugs, sources and industry analysts told the Chicago Tribune. Report

Suggested Articles

Pharma

How life sciences brands can win on mobile, right now

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Sponsored by Rebecca Willumson
shkreli
Pharma

Supreme Court refuses to take up Shkreli's conviction appeal

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

by Kyle Blankenship
OxyContin
Pharma

How Purdue planted the opioid 'anti-story'

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.

by David Armstrong, ProPublica